Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis-Reference-Cited by-同舟云学术

Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis

Published:2022-07 Issue: Volume:170 Page:119-130
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ajani Jaffer A.,Leung Lisa^ORCID,Singh Prianka,Kurt Murat,Kim Inkyu,Pourrahmat Mir-Masoud^ORCID,Kanters Steve

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference59 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Ca - Cancer J Clin,2018

2. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Lordick;Ann Oncol,2016

3. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology;Ajani;J Natl Compr Cancer Netw,2019

4. Is there a precise adjuvant therapy for esophagogastric carcinoma?;Cartwright;Am Soc Clin Oncol Educ Book,2018

5. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer;Kelly;N Engl J Med,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study;Cancer Immunology, Immunotherapy;2024-09-09

2. Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohort;JNCI: Journal of the National Cancer Institute;2024-06-26

3. Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma;British Journal of Surgery;2024-01-31

4. A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial;International Journal of Radiation Oncology*Biology*Physics;2023-11

5. Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed;Nature Reviews Clinical Oncology;2023-10-12